Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Biology / Biochemistry News

Symyx Showcases Research Services For Refining At 14th International Congress On Catalysis

Main Category: Biology / Biochemistry
Article Date: 15 Jul 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Symyx Technologies, Inc. (NASDAQ: SMMX) announced, at the opening of the 14th Annual International Congress of Catalysis, the expansion of Symyx Research to include Refining R&D services. Symyx is showcasing its capabilities at the International Congress on Catalysis in Seoul, Korea, from July 14 to 18, 2008. Symyx Research for Refining provides companies with small scope, flexible service projects where clients pay per experiment, allowing scientists to access capability when and where they need it. The company's expertise is based on more than 10 years of catalyst development experience throughout the petrochemical and chemical industries,

"Refiners around the world are facing increasing environmental regulations, decreasing margins, and lower-quality feedstocks. It is critically important for chemists and researchers in the refining industry to develop and evaluate new catalysts to address these challenges," said Richard Boehner, president of Symyx Research. "Refining companies have catalyst experts. Symyx Research for Refining provides a means for these scientists to access results for experiments in experimental spaces they define."

Symyx Research for Refining gives companies access to Symyx's installed base of high-throughput experimentation technology and analytics as well as expert staff to synthesize and screen new catalyst libraries or screen client-provided catalysts for catalytic performance. This flexible, fee-for-service model allows the client to define experiment sets, own the scientific IP and pay no royalties. Infrastructure available through Symyx Research for Refining includes catalyst research and development capabilities for naphtha hydrodesulfurization, diesel hydrodesulfurization (& HDN), reforming, VGO hydrotreating, hydrocracking, lubes hydrotreating and alkylation.

With Symyx Research for Refining, the world's leaders in refining technology can reduce the number of pilot plant runs required for catalyst development by executing lab scale 'pilot plant representative' studies to identify catalysts and conditions that yield greater probabilities of success. In addition, proprietary fixed-bed reactor technology for gas phase reactions and trickle-bed reactor technology for high conversion studies gives companies representative pilot plant data without investing in additional infrastructure.

"Clients can now access pilot plant quality data from laboratory reactors, using real feedstocks," said Sam Bergh, Vice President of Engineering, Symyx Technologies, Inc. "This enables researchers to select catalysts with the greatest probability of success without having to perform numerous costly and time-consuming pilot plant runs on each candidate. Symyx Research provides not only a service to synthesize catalyst libraries but also to screen those catalysts in only a few months."

Scientists from Symyx are available to discuss Research for Refining capabilities at the International Congress on Catalysis in Seoul, Korea, July 14-18, 2008 at Booth #22-23. For more information, visit: http://www.symyx.com.

About Symyx

Symyx Technologies, Inc. is the scientific R&D integration partner to companies in the life sciences, chemicals, energy, electronics and consumer products industries. With scientific R&D under tremendous economic and technical pressure, Symyx helps companies reduce R&D risk and enhance R&D productivity to help them bring more and better products to market quickly and cost-effectively. Symyx's integrated technology platform combines electronic laboratory notebooks, content, laboratory logistics and analysis available from Symyx Software, software-driven integrated workflows available from Symyx Tools and collaborative research and directed services from Symyx Research to support the entire R&D process. Information about Symyx, including reports and other information filed by Symyx with the Securities and Exchange Commission, is available at http://www.symyx.com.

Symyx is a registered trademark of Symyx Technologies, Inc. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Symyx Technologies, Inc.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Nutrition? Why Is Nutrition Important?
16 Aug 2009
Nutrition, nourishment, or aliment, is the supply of materials - food - required by organisms and cells to stay alive. In science and human medicine, nutrition is the science or practice of consuming and utilizing foods...


How to Build a Better Relationship with Your Doctor
How to Build a Better Relationship with Your Doctor

With appointments lasting 15 minutes or less, it can be hard to communicate with your doctor. But there are some tips on how to get the most out of your visit.

more videos are available in our health videos section.